Mackenzie Financial Corp Has $35.33 Million Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Mackenzie Financial Corp lifted its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 4.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 86,827 shares of the pharmaceutical company’s stock after purchasing an additional 3,856 shares during […]

Related Keywords

Canada ,Robertw Baird ,Stuarta Arbuckle , ,Arlington Trust Co ,Baystate Wealth Management ,Wolfe Research ,Mackenzie Financial Corp ,Jpmorgan Chase Co ,Vertex Pharmaceuticals ,Vertex Pharmaceuticals Incorporated ,Vertex Pharmaceuticals Trading Down ,Vertex Pharmaceuticals Company Profile ,Fortitude Family Office ,News Ratings For Vertex Pharmaceuticals Daily ,Royal Bank ,Quarter For Vertex Pharmaceuticals ,Maxim Group ,Cornerstone Planning Group ,Securities Exchange Commission ,Free Report ,Financial Corp ,Family Office ,Wealth Management ,Asset Management ,Chairman Jeffrey ,Pharmaceuticals Trading Down ,Get Free Report ,Pharmaceuticals Incorporated ,Visit Holdingschannel ,Vertex Pharmaceuticals Daily ,